stockrow
Friday 6 November 2026
Export ARAY’s income statement to Excel — free account
Accuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025.
- Revenue
- −7.90%
- EPS
- +138.9%
- Free cash flow
- −138.3%
- Total debt
- −25.4%
Quarter to September 2026, against a year earlier
0.11
0.01
−8.33%
Follow ARAY
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (30.23%) | (80.08%) | (101.06%) | (70.32%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
— | 1 | 2 | 3 | |
| (4.10%) | (10.77%) | (9.90%) | (7.69%) | ||
ROIC |
(21.79%) | (11.25%) | (12.63%) | (8.07%) | |
Return on Tangible Assets |
(14.26%) | (39.77%) | (39.64%) | (29.15%) | |
Average Days of Receivables |
0.00 | 61.21 | 54.99 | 50.92 | |
Free Cash Flow per Share |
(0.20) | (0.10) | (0.21) | (0.02) | |
Free Cash Flow |
(27.05) | (12.84) | (25.84) | (2.66) | |
Capital Expenditures |
(4.08) | (5.86) | (6.72) | (7.21) | |
| Other line items | |||||
Cash ROIC |
(18.27%) | (5.60%) | (12.06%) | (1.21%) | |
Accounts Receivable Turnover |
0.00 | 5.34 | 6.00 | 5.90 | |
Accounts Payable Turnover |
0.00 | 7.79 | 6.33 | 6.48 | |
Inventory Turnover |
0.00 | 2.02 | 2.07 | 2.11 | |
Average Days of Payables |
0.00 | 50.96 | 61.44 | 50.31 | |
Days of Inventory on Hand |
0.00 | 184.80 | 182.25 | 174.51 | |
Tax Rate |
0.13 | 0.04 | 0.06 | 0.07 | |
Research and Development Expense of Revenue |
0.00% | 9.39% | 9.72% | 10.12% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 20.89% | 20.61% | 20.26% | |
Share Based Compensation of Revenue |
1.28% | 1.61% | 1.77% | 2.05% | |
Interest Coverage |
(1.41) | (0.80) | (0.98) | (0.77) | |
Operating CF/Net income |
1.32 | 0.14 | 0.41 | (0.13) | |
Depreciation/Fixed assets |
0.74 | 0.59 | 0.48 | 0.39 | |
Capex/Depreciation |
(0.21) | (0.37) | (0.48) | (0.63) | |
Revenue per Share |
2.85 | 3.28 | 3.45 | 3.61 | |
Operating CF per Share |
(0.17) | (0.06) | (0.15) | 0.04 | |
Capex per Share |
(0.03) | (0.05) | (0.05) | (0.06) | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026